Matthew E. Nielsen - Concepedia

Author

Matthew E. Nielsen

University of North Carolina at Chapel Hill ORCID

Also Known As

Andrew Z. Wang, Carpenter, William R., Deal, Allison M., Filippou, Pauline, Jonsson, Mattias, Koontz, Bridget F., M Nielsen, M. E. Nielsen, M. Nielsen, M.E. Nielsen

465

Publications

11.4K

Citations

H-Index

125

Concepts

All Affiliations

University of North Carolina at Chapel Hill UNC Lineberger Comprehensive Cancer Center Johns Hopkins University Johns Hopkins Hospital The University of Texas Southwestern Medical Center

About

Matthew E. Nielsen is an author at University of North Carolina at Chapel Hill specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	55	4K
2	Engineering	2	2	31
3	Health Sciences	2	2	69
4	Nursing	2	2	45
5	Education	1	1	33

Matthew E. Nielsen

127

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Prospective Randomized Controlled Trial of Robotic versus Open Radical Cystectomy for Bladder Cancer: Perioperative and Pathologic Results Jeff Nix, Angela B. Smith, Raj Kurpad, European Urology UrologySurgical OncologyPathologic ResultsRobotic TechnologyMedicine	2009	543
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns A. Rose Brannon, Anupama Reddy, Michael Seiler, Genes & Cancer Consensuscluster AnalysisUrologyOncologyGenitourinary CancerTumor Heterogeneity	2010	323
Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer Ronald C. Chen, Ramsankar Basak, Anne-Marie Meyer, JAMA	2017	322
ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma Samira A. Brooks, A. Rose Brannon, Joel S. Parker, European Urology Prognostic Risk PredictorPrognostic BiomarkersUrologyCancer RiskGenitourinary Cancer	2014	301
Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma C. Lance Cowey, Chirag Amin, Raj S. Pruthi, Journal of Clinical Oncology	2010	197
Exploring the Burden of Inpatient Readmissions After Major Cancer Surgery Karyn B. Stitzenberg, YunKyung Chang, Angela B. Smith, Journal of Clinical Oncology	2014	192
Cancer Incidence Among US Medicare ESRD Patients Receiving Hemodialysis, 1996-2009 Anne M. Butler, Andrew F. Olshan, Abhijit V. Kshirsagar, American Journal of Kidney Diseases HemodialysisOncologyCancer EpidemiologyHealth PolicyKidney Failure	2015	191
Robotic Radical Cystectomy for Bladder Cancer: Surgical and Pathological Outcomes in 100 Consecutive Cases Raj S. Pruthi, Matthew E. Nielsen, Jeff Nix, The Journal of Urology	2009	185
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience Tracy L. Rose, William H. Weir, Gregory M. Mayhew, British Journal of Cancer Checkpoint InhibitionUrologyMetastatic Urothelial CancerGenitourinary CancerImmunology	2021	185
Roles for the Stem Cell–Associated Intermediate Filament Nestin in Prostate Cancer Migration and Metastasis Wolfram Kleeberger, G. Steven Bova, Matthew E. Nielsen, Cancer Research	2007	182

Page 1